December 13, 2023

Maryland Medicaid’s Preferred Drug List (PDL)

Effective January 1, 2024

The Office of Pharmacy Services (OPS) wants to alert you to updates to the Maryland Medicaid’s Preferred Drug List (PDL) and Brand Preferred over Generic Program, effective January 1, 2024.

Please refer to the Maryland Department of Health website for the complete PDL and Brand Preferred over Generic List.

Generic vs. Brand Status on Maryland Medicaid’s PDL: The PDL encompassing over 1800 drugs, covers most generic formulations of preferred multisource brand drugs without a prior authorization. If the prescription for a brand name drug is to be dispensed as written (DAW6), the prescriber must complete and submit a Medwatch form. https://health.maryland.gov/mm.... The OPS clinical pharmacy team will review the Medwatch form and notify the prescriber whether the request for the brand name drug is approved or denied. The State will forward the Medwatch form to the FDA when appropriate.